S D Donevan

Summary

Affiliation: Parke-Davis Pharmaceutical Research
Country: USA

Publications

  1. ncbi Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors
    S D Donevan
    Department of Neurology, University of Utah, USA
    Mol Pharmacol 58:614-23. 2000

Detail Information

Publications1

  1. ncbi Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors
    S D Donevan
    Department of Neurology, University of Utah, USA
    Mol Pharmacol 58:614-23. 2000
    ..These results demonstrate that Con G is a subunit-specific competitive antagonist of NMDA receptors. The unique subunit selectivity profile of Con G may explain its favorable in vivo profile compared with nonselective NMDA antagonists...